A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis

Published:2017-09 Issue: Volume:53 Page:31-42
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Pandey Manoj K.,Gowda Krishne,Sung Shen-shu,Abraham Thomas,Budak-Alpdogan Tulin,Talamo Giampolo,Dovat Sinisa,Amin Shantu

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference70 articles.

1. Multiple myeloma;Palumbo;N Engl J Med,2011

2. Targeting Bruton's tyrosine kinase in B cell malignancies;Hendriks;Nat Rev Cancer,2014

3. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases;Rawlings;Science,1996

4. Regulation of Btk function by a major autophosphorylation site within the SH3 domain;Park;Immunity,1996

5. Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2;Kim;Mol Cell Biol,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells;Heliyon;2024-06

2. Quinazoline‐chalcone hybrids as HDAC/EGFR dual inhibitors: Design, synthesis, mechanistic, and in‐silico studies of potential anticancer activity against multiple myeloma;Archiv der Pharmazie;2024-01-31

3. Thiazole, isatin and phthalimide derivatives tested in vivo against cancer models: a literature review of the last six years;Current Medicinal Chemistry;2023-04-26

4. Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells;Frontiers in Pharmacology;2022-09-09

5. Medicinal Chemistry Strategies for the Development of Bruton’s Tyrosine Kinase Inhibitors against Resistance;Journal of Medicinal Chemistry;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3